Neoadjuvant PD-1 Blockade with Sintilimab in Mismatch-Repair Deficient, Locally Advanced Rectal Cancer: An Open-Label, Single-Centre Phase 2 Study - Chen, G; Jin, Y; Guan, WL (Lancet Gastroenterol Hepatol, 2023)
et al.